Reaching Laboratory Directors by Name: What Public Data Can and Can't Do

The challenge

If you sell lab instruments, assays, reagents or testing services, your buyer is often one person: the laboratory director. Every certified clinical lab in the US must have one, yet no public directory lists them by name, and job-title data misses most of them.

We set out to learn how many lab directors can be identified and reached through NPI targeting, using only public CMS data. The answer: 8,577 physicians who likely direct 9,991 labs. That's 39% of the 25,567 active labs doing moderate- and high-complexity testing in physician offices, hospitals and independent labs.

How we found them

We stopped searching for people with the right title and started from the labs themselves.

Job titles were a dead end

Searching provider registries and nonprofit tax filings for "laboratory director" turned up only a few hundred names, and more than half weren't physicians. Lab directors rarely appear among an organization's officers or top-paid staff, so title-based lists miss most of them.

Starting from the labs

Every US lab that tests patient specimens is certified by CMS under CLIA, and those certification records are public. They describe each lab: what kind of lab it is, where it is and how complex its testing is. They don't name the director.

So we flipped the question. Of the roughly 33,000 active labs doing moderate- and high-complexity testing, we set aside community clinics and other facility types, leaving 25,567 physician office, hospital and independent labs. For each one, we asked which physician most likely runs it.

Connecting labs to physicians

We linked each lab to physicians in the national NPI registry using public CMS and NPPES records, then weighed several independent signals to pick the most likely director. For hospital labs, we also drew on which pathologists are affiliated with that hospital.

The records also show which labs share a director. A match at one lab can carry to that director's other sites, and directors who run several labs stand out.

Grading confidence instead of guessing

No single signal is perfect, so every match carries a confidence grade. Where independent signals agreed, the match graded High. Where they conflicted, we tested which signals held up and downgraded the weaker ones: one promising signal agreed with other evidence only about half the time, so matches resting on it are graded Low.

The result

High and Medium together come to 7,388 physicians, enough for a standard NPI campaign by themselves.

Lab-type columns count physicians and overlap slightly, because some physicians direct more than one type of lab.

What each tier means:

• High: independent signals agree, or the physician is the only plausible candidate at the lab.
• Medium: solid evidence from one signal, but a second signal is missing or points elsewhere.
• Low: the match rests on a signal that proved less reliable in testing.

Why we focused on directors with an NPI

Covering 39% of labs was a deliberate choice. An NPI is what lets a campaign reach a specific, named person online and confirm afterward who it reached.

Most digital targeting reaches people by proxy: a job title on a social profile, the websites they visit, or a place they pass through. Each proxy includes people who aren't your buyer and misses many who are. NPI targeting works the other way around. It starts with a list of the exact providers you want and matches them to their online identifiers.

That changes what you can know and do:

• You reach the person, not a profile. Ads go to the lab directors on your list, identified by NPI, rather than to anyone with "lab" in a job title.
• You see who engaged, by name. Provider-level reporting shows which directors saw your message, which clicked and which took an online action, identified by name and NPI, with no form fill required.
• Your sales team has a place to start. Directors who engage can be prioritized for follow-up, sorted by territory and added to your CRM.
• Results are measured against your list. Every provider counted is identified, so reach and engagement are measured against the audience you chose, not an estimate.

The trade-off is coverage. Directors without an NPI, mostly PhD scientists, can't be reached this way, and many labs couldn't be tied to one physician with confidence. A narrower audience you can name and measure is often worth more than a broad one you can't. For the rest, channels such as conference geofencing or account-based outreach to the lab's organization can run alongside.

How the audience can be customized

The audience can be cut five ways to match who a client sells to.

By confidence tier

High plus Medium (7,388) is the default. Low can be added when reach matters more than precision, or left out when it doesn't.

By lab type

• Physician office labs (about 6,000 directors): practicing clinicians who run their own in-office labs. The easiest group to match, and nearly all have NPIs.
• Hospital labs (about 1,800): mostly pathologists running hospital laboratories.
• Independent labs (about 960): pathologists, plus specialty practices with their own reference labs.

By specialty

• Pathologists only (1,663): the classic lab-director buyer.
• Dermatology: the largest group among office labs, because Mohs surgery practices run their own tissue labs.
• Pain medicine and anesthesiology: practices that run in-house drug-testing labs.
• Urology, OB/GYN, internal and family medicine: in-office testing labs.

By scale

1,013 physicians direct more than one lab. One decision from them affects several sites, which makes them the highest-value slice.

By geography

Lab or practice state, as with any NPI segment.

Built for prospect review

Each row shows the method behind the match and lists up to ten of the physician's labs with CLIA numbers, so a prospect can check the list for themselves.

What we couldn't resolve

About 61% of labs in scope still have no director assigned. The main reasons:

• Large hospital labs. 2,778 hospital labs have several pathologists on staff, and public data doesn't say which one directs the lab.
• Directors without an NPI. More than half of independent labs (2,785) had no physician linked at all. Most are likely run by PhD scientists, who usually don't have an NPI, or are large commercial lab sites whose directors work elsewhere.
• Large group practices. Many office labs sit in practices with six or more physicians and no clear signal pointing to one of them.
• Imperfect public records. Registry details are self-reported and not always current, which weakens some matches, especially in the Low tier.
• Incomplete links between labs. The records list only some of the labs a director runs, so a few multi-lab directors look smaller than they are.
• Scope. Labs doing only simple waived tests, and community clinic and other lab types, weren't included.
• No public list of names. CLIA records don't publish director names, so every match here is an inference from public data, graded by confidence, not a confirmed identity.

About the data

Sources: CMS CLIA laboratory records (Q2 2026), the NPPES NPI registry (August 2026), CMS facility affiliation data (August 2026) and CMS hospital data (July 2026). Counts verified October 7, 2026. Scope: active labs certified for moderate- or high-complexity testing in physician offices, hospitals and independent labs.

Reaching this audience with PrioritySignal™

PrioritySignal™ is how DigiVidBio turns a priority audience like this one into provider-level intelligence your team can act on. It moves in four steps: Priority Audience, Provider Engagement, Provider Intelligence, Commercial Activation.

We start with the audience. Together we define which lab directors matter most for your product, whether that's pathologists at hospital labs, dermatology practices running Mohs labs, or directors who oversee several sites, and size the list before anything runs. Campaigns typically begin with programmatic display delivered to those directors, then add video, rich media, streaming and social as performance shows what works.

As the campaign runs, you see which directors are engaging, by name and NPI, so marketing and sales can decide where to focus next. If lab directors are on your target list, we'd welcome the chance to discuss your audience and what it would take to reach it.

Discuss your HCP strategy →

Q&A: Reaching Laboratory Directors by Name

How many lab directors can public data identify?

We identified 8,577 physicians who likely direct 9,991 labs. That covers 39% of the 25,567 active labs doing moderate- and high-complexity testing in physician offices, hospitals and independent labs.

Why not search by job title?

‍Lab directors rarely show up among an organization's officers or top-paid staff. Title searches found only a few hundred names, and more than half weren't physicians. So we started from the labs and linked each one to a likely physician in the NPI registry.

How reliable are the matches?

‍Every match gets a confidence grade of High, Medium or Low. High means independent signals agree. Medium means one solid signal. Low means the match rests on a signal that proved less reliable. High and Medium together total 7,388 physicians, enough for a standard NPI campaign.

Why target by NPI?

‍It reaches the named director instead of a job-title proxy. You also see who engaged, by name and NPI. The trade-off is coverage, because directors without an NPI, mostly PhD scientists, can't be reached this way.

Can the audience be customized?

‍Yes. It can be cut by confidence tier, lab type, specialty, scale and geography. For example, 1,013 physicians direct more than one lab.